Patents by Inventor Stephen C. Lee

Stephen C. Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12007593
    Abstract: An OLED display including a display panel and a color-correction component is described. A plurality of comparative display panels otherwise equivalent to the display panel but having one or more different optical thicknesses of OLED layers have a maximum white-point color shift from 0 to 45 degrees of WPCSC45 and a white-point axial efficiency of WPAEC. The plurality of comparative display panels defines a performance curve along a boundary of performance points. The OLED display and the display panel have respective maximum white-point color shifts from 0 to 45 degrees of WPCS45 and WPCS045 and respective white-point axial efficiencies of WPAE and WPAE0. WPCS045 and WPAE0 defines a performance point of the display panel to the right of the performance curve and WPCS45 and WPAE defines a performance point of the OLED display above or to the left of the performance curve. Methods of making the OLED display are described.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: June 11, 2024
    Assignee: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Nicholas C. Erickson, David G. Freier, Robert L Brott, Bing Hao, David A. Rosen, Stephen M. Menke, Bert T. Chien, Seong Taek Lee, Encai Hao, Zhaohui Yang, Albert I. Everaerts, Yongshang Lu, William Blake Kolb, Keith R. Bruesewitz, Adam D. Haag, Sun-Yong Park, Timothy J. Nevitt, Brianna N. Wheeler, Jody L. Peterson, Gilles J. Benoit
  • Patent number: 10585092
    Abstract: Disclosed are field effect transistor-based (FET-based) sensors for the rapid and accurate detection of analytes both in vivo and in vitro. The FET-based sensors can include a substrate, a channel disposed on the substrate, a source electrode and a drain electrode electrically connected to the channel, and a recognition element for an analyte of interest immobilized on the surface of the channel via a linking group. The distance between the recognition element and the channel can be configured such that association of the analyte of interest with the recognition element induces a change in the electrical properties of the channel. In this way, an analyte of interest can be detected by measuring a change in an electrical property of the channel. Also provided are devices, including probes and multi-well plates, incorporating the FET-based sensors.
    Type: Grant
    Filed: January 17, 2017
    Date of Patent: March 10, 2020
    Assignee: OHIO STATE INNOVATION FOUNDATION
    Inventors: Stephen C. Lee, Wu Lu, Leonard J. Brillson, Gregg A. Hadley, Ronald P. Pelletier, Paul R. Berger
  • Publication number: 20170131267
    Abstract: Disclosed are field effect transistor-based (FET-based) sensors for the rapid and accurate detection of analytes both in vivo and in vitro. The FET-based sensors can include a substrate, a channel disposed on the substrate, a source electrode and a drain electrode electrically connected to the channel, and a recognition element for an analyte of interest immobilized on the surface of the channel via a linking group. The distance between the recognition element and the channel can be configured such that association of the analyte of interest with the recognition element induces a change in the electrical properties of the channel. In this way, an analyte of interest can be detected by measuring a change in an electrical property of the channel. Also provided are devices, including probes and multi-well plates, incorporating the FET-based sensors.
    Type: Application
    Filed: January 17, 2017
    Publication date: May 11, 2017
    Inventors: Stephen C. Lee, Wu Lu, Leonard J. Brillson, Gregg A. Hadley, Ronald P. Pelletier, Paul R. Berger
  • Publication number: 20100129289
    Abstract: Targeting polypeptide imaging agents, methods employing the agents, and kits employing the agents are provided. The targeting polypeptide imaging agents may have at least one targeting polypeptide and at least one contrast enhancing imaging agent.
    Type: Application
    Filed: May 18, 2007
    Publication date: May 27, 2010
    Applicant: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION
    Inventors: Stephen C. Lee, Andrew D. Kebbel
  • Publication number: 20040236514
    Abstract: The present invention describes a novel method for the design of polypeptides with controlled distribution of immunogentic epitopes. The method allows for the controlled elimination or introductionof epitopes in consideration of major histocompatibility complex (MHC) molecule binding motifs.
    Type: Application
    Filed: December 13, 2002
    Publication date: November 25, 2004
    Inventors: Stephen C. Lee, Neena L. Summers
  • Publication number: 20040171115
    Abstract: Disclosed are novel multi-functional hematopoietic receptor agonist proteins, DNAs which encode the multi-functional hematopoietic receptor agonists proteins, methods of making the multi-functional hematopoietic receptor agonists proteins and methods of using the multi-functional hematopoietic receptor agonists proteins.
    Type: Application
    Filed: October 27, 2003
    Publication date: September 2, 2004
    Inventors: Yiqing Feng, Nicholas R. Staten, Charles M. Baum, Neena L. Summers, Maire Helena Caparon, S. Christopher Bauer, Linda L. Zurfluh, John P. McKearn, Barbara K. Klein, Stephen C. Lee, Charles A. McWherter, Judith G. Giri
  • Publication number: 20040131584
    Abstract: The present invention relates to site-specific conjugation of synthetic particles to proteins.
    Type: Application
    Filed: November 25, 2003
    Publication date: July 8, 2004
    Applicant: G. D. Searle & Co.
    Inventors: Stephen C. Lee, Ranjani V. Parthasarathy
  • Patent number: 6730303
    Abstract: Disclosed are novel multi-functional hematopoietic receptor agonist proteins, DNAs which encode the multi-functional hematopoietic receptor agonists proteins, methods of making the multi-functional hematopoietic receptor agonists proteins and methods of using the multi-functional hematopoietic receptor agonists proteins.
    Type: Grant
    Filed: February 22, 2000
    Date of Patent: May 4, 2004
    Assignee: Pharmacia Corporation
    Inventors: Yiqing Feng, Nicholas R. Staten, Charles M. Baum, Neena L. Summers, Maire Helena Caparon, S. Christopher Bauer, Linda L. Zurfluh, John P. McKearn, Barbara K. Klein, Stephen C. Lee, Charles A. McWherter, Judith G. Giri
  • Patent number: 6682727
    Abstract: The present invention relates to site-specific conjugation of synthetic particles to proteins.
    Type: Grant
    Filed: October 18, 2001
    Date of Patent: January 27, 2004
    Assignee: G. D. Searle & Co.
    Inventors: Stephen C. Lee, Ranjani V. Parthasarathy
  • Publication number: 20020187198
    Abstract: The present invention relates to site-specific conjugation of synthetic particles to proteins.
    Type: Application
    Filed: October 18, 2001
    Publication date: December 12, 2002
    Inventor: Stephen C. Lee
  • Patent number: 6485718
    Abstract: The present invention relates to site-specific conjugation of synthetic particles to proteins.
    Type: Grant
    Filed: April 11, 2000
    Date of Patent: November 26, 2002
    Assignee: Pharmacia Corporation
    Inventors: Rajani V. Parthasarathy, Stephen C. Lee
  • Patent number: 6066318
    Abstract: Disclosed are novel multi-functional hematopoietic receptor agonist proteins, DNAs which encode the multi-functional hematopoietic receptor agonists proteins, methods of making the multi-functional hematopoietic receptor agonists proteins and methods of using the multi-functional hematopoietic receptor agonists proteins.
    Type: Grant
    Filed: April 4, 1997
    Date of Patent: May 23, 2000
    Assignee: G.D. Searle & Co.
    Inventors: Yiqing Feng, Nicholas R. Staten, Charles M. Baum, Neena L. Summers, Maire Helena Caparon, S. Christopher Bauer, Linda L. Zurfluh, John P. McKearn, Barbara K. Klein, Stephen C. Lee, Charles A. McWherter, Judith G. Giri
  • Patent number: 5348886
    Abstract: A method for producing infectious recombinant baculoviruses in bacteria is described. A novel baculovirus shuttle vector (bacmid) was constructed that contains a low-copy-number bacterial replicon, a selectable drug resistance marker, and a preferred attachment site for a site-specific bacterial transposon, inserted into a nonessential locus of the baculovirus genome. This shuttle vector can replicate in E. coli as a plasmid and is stably inherited and structurally stable after many generations of growth. Bacmid DNA isolated from E. coli is infectious when introduced into susceptible lepidopteran insect cells. DNA segments containing a viral promoter driving expression of a foreign gene in insect cells that are flanked by the left and right ends of the site-specific transposon can transpose to the attachment site in the bacmid propagated in E. coli when transposition functions are provided in trans by a helper plasmid.
    Type: Grant
    Filed: September 4, 1992
    Date of Patent: September 20, 1994
    Assignee: Monsanto Company
    Inventors: Stephen C. Lee, Mark S. Leusch, Verne A. Luckow, Peter O. Olins